Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled Trial

T. Sajobi, Tolulope; I. Arimoro, Olayinka; Ademola, Ayoola; Singh, Nishita; Bala, Fouzi; Almekhlafi, Mohammed; Deschaintre, Yan; B. Coutts, Shelagh; Thirunavukkarasu, Sibi; Khosravani, Houman; Appireddy, Ramana; Moreau, F.; Gubitz, Gordon; Tkach, Aleksander; Catanese, Luciana; Dowlatshahi, Dar; Medvedev, George; Mandzia, Jennifer; Pikula, Aleksandra; Shankar, Jai; Williams, Heather; S. Field, Thalia; Manosalva, Alejandro; Siddiqui, Muzaffar; Zafar, Atif; Imoukhuede, Oje; Hunter, Gary; M. Demchuk, Andrew; Mishra, Sachin; C. Gioia, Laura; Jalini, Shirin; Cayer, Caroline; Phillips, Stephen; Elamin, Elsadig; Shoamanesh, Ashkan; Subramaniam, Suresh; Kate, Mahesh; Jacquin, Grégory; Camden, Marie‐Christine; Benali, Faysal; Alhabli, Ibrahim; Horn, MacKenzie; Stotts, Grant; D. Hill, Michael; J. Gladstone, David; Y. Poppe, Alexandre; Sehgal, Arshia; Zhang, Qiao; Cord Lethebe, Brendan; Doram, Craig; Shamy, Michel; Kenney, Carol; Buck, Brian; H. Swartz, Richard; K. Menon, Bijoy

doi:10.1161/strokeaha.123.044690

Public

Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled Trial

Published in Stroke • Jan 26, 2024

Authors:

Tolulope T. Sajobi

Olayinka I. Arimoro

Ayoola Ademola

Abstract

BACKGROUND: Recent evidence from thrombolysis trials indicates the noninferiority of intravenous tenecteplase to intravenous alteplase with respect to good functional outcomes in patients with acute stroke. We examined whether the health-related quality of life (HRQOL) of patients with acute stroke ...

Subject

Medicine

Tenecteplase

Thrombolysis

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!